Bohen Sean
- SEC CIK
- 0001831218
No open-market purchases or sales filed in the past year.
Current role at each company
- OLMA Olema Pharmaceuticals, Inc.PRESIDENT AND CEOas of Feb 4, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bohen Sean as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2024 (view filing) | Dec 10-11 | 1 day | Bohen SeanPRESIDENT AND CEO | SSale | −109.5K | $9.01 | −$986.4K | −31.2%241.7K after | 3 lots |
| Nov 22, 2023 (view filing) | Nov 21-22 | 1 day | Bohen SeanPRESIDENT AND CEO | SSale | −57.2K | $14.40 | −$824.1K | −28.3%144.9K after | 3 lots |
| Sep 23, 2022 (view filing) | Sep 21 | 2 days | Bohen SeanPRESIDENT AND CEO | PPurchase | +20.0K | – | – | +36.8%74.3K after | Amended |
| Oct 15, 2021 (view filing) | Oct 14 | 1 day | Bohen SeanPRESIDENT AND CEO | SSale | −5.00K | $30.47 | −$152.4K | −8.7%52.5K after | 2 lots |
| Sep 29, 2021 (view filing) | Sep 27 | 2 days | Bohen SeanPRESIDENT AND CEO | SSale | −1.08K | $30.07 | −$32.6K | −2.0%52.5K after | |
| Sep 9, 2021 (view filing) | Sep 7-8 | 2 days | Bohen SeanPRESIDENT AND CEO | SSale | −3.04K | $30.01 | −$91.4K | −5.5%52.5K after | 2 lots |
| Sep 3, 2021 (view filing) | Sep 1 | 2 days | Bohen SeanPRESIDENT AND CEO | SSale | −871 | $30.05 | −$26.2K | −1.6%54.3K after |